US Stock MarketDetailed Quotes

TOI The Oncology Institute

Watchlist
  • 0.1540
  • -0.0010-0.65%
Close Nov 22 16:00 ET
  • 0.1520
  • -0.0020-1.30%
Post 18:23 ET
11.64MMarket Cap-200P/E (TTM)

The Oncology Institute Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
59.26%-8.31M
16.56%-8.66M
9.00%-15.45M
-88.97%-61.76M
40.02%-14M
Net income from continuing operations
7.50%-16.11M
8.39%-15.48M
33.70%-19.89M
-54,750.00%-83.07M
-70.38%-18.75M
-551.42%-17.42M
-209.87%-16.9M
-255.54%-30M
101.39%152K
-8.38%-11.01M
Operating gains losses
-128.62%-571K
-311.38%-2.53M
100.35%12K
97.63%-622K
114.46%1.46M
113.00%2M
70.22%-615K
-367.88%-3.46M
-203.19%-26.21M
-191.84%-10.09M
Depreciation and amortization
-7.36%1.57M
14.22%1.52M
17.34%1.49M
33.14%5.87M
32.30%1.58M
49.74%1.7M
21.04%1.33M
28.57%1.27M
32.03%4.41M
29.57%1.19M
Deferred tax
--0
--0
--0
71.10%-76K
71.75%-126K
53.85%80K
91.84%-4K
-114.44%-26K
78.82%-263K
-119.43%-446K
Other non cash items
106.67%2.14M
-50.22%1.01M
102.20%1.56M
109.52%5.4M
140.63%1.56M
138.49%1.04M
118.84%2.04M
101.95%771K
-128.57%-56.77M
84.56%-3.84M
Change In working capital
1,131.77%11.46M
-289.12%-3.41M
42.81%-2.73M
111.48%2.36M
223.53%6.45M
85.38%-1.11M
564.58%1.8M
40.24%-4.78M
-41.77%-20.54M
58.85%-5.22M
-Change in receivables
75.90%-493K
1,040.91%4.76M
-172.46%-16.22M
77.13%-4.5M
178.12%4.01M
66.74%-2.05M
86.26%-506K
-26.58%-5.95M
-558.35%-19.67M
-435.82%-5.13M
-Change in inventory
20,366.67%1.22M
112.12%232K
313.90%2.12M
-153.18%-4.39M
-272.77%-1.47M
99.29%-6K
-377.31%-1.91M
25.45%-993K
5.97%-1.73M
269.72%852K
-Change in prepaid assets
-93.89%100K
-53.27%521K
-2,520.83%-629K
-26.95%3.13M
-45.73%400K
-31.59%1.64M
60.20%1.12M
-105.26%-24K
147.10%4.28M
108.08%737K
-Change in payables and accrued expense
1,953.56%10.42M
-365.56%-8.85M
562.80%11.73M
319.62%8.16M
247.11%3.62M
73.97%-562K
-0.24%3.33M
172.59%1.77M
-214.83%-3.72M
82.27%-2.46M
-Change in other current assets
-107.35%-97K
-75.81%410K
29.33%1.75M
9.05%5.72M
-18.65%1.36M
-10.45%1.32M
44.38%1.7M
45.01%1.35M
2,750.00%5.25M
-81.52%1.67M
-Change in other current liabilities
122.01%320K
75.08%-479K
-59.76%-1.48M
-16.32%-5.77M
-65.05%-1.46M
36.95%-1.45M
-124.53%-1.92M
-1.98%-927K
-712.86%-4.96M
-427.31%-887K
Cash from discontinued investing activities
Operating cash flow
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
59.26%-8.31M
16.56%-8.66M
9.00%-15.45M
-88.97%-61.76M
40.02%-14M
Investing cash flow
Cash flow from continuing investing activities
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
108.78%7.71M
342.67%24.9M
1,936.43%18.4M
-982.89%-131.61M
-255.93%-32.57M
Net PPE purchase and sale
143.23%402K
-94.88%-1.83M
66.83%-610K
17.40%-4.57M
56.84%-861K
21.85%-930K
30.18%-937K
-83.53%-1.84M
-94.20%-5.53M
-129.05%-2M
Net business purchase and sale
--0
----
----
48.05%-4.46M
66.81%-156K
--0
----
----
5.82%-8.58M
94.32%-470K
Net investment purchase and sale
15.75%10M
-33.64%20M
-1.20%20M
160.99%71.66M
142.00%12.64M
109.88%8.64M
--30.14M
--20.24M
---117.51M
---30.11M
Cash from discontinued investing activities
Investing cash flow
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
108.78%7.71M
342.67%24.9M
1,936.43%18.4M
-982.89%-131.61M
-255.93%-32.57M
Financing cash flow
Cash flow from continuing financing activities
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
-100.72%-756K
75.66%-2.6M
-3.14%-1.71M
-40.13%92.21M
-100.62%-847K
Net issuance payments of debt
-10.00%-11K
85.71%-9K
50.00%-9K
-100.09%-101K
47.37%-10K
-100.01%-10K
-384.62%-63K
-38.46%-18K
1,616.23%109.94M
99.63%-19K
Net common stock issuance
--0
----
----
88.68%-1.02M
--0
---125K
----
----
---9M
--0
Proceeds from stock option exercised by employees
--0
--2K
--73K
-85.31%126K
-74.43%113K
-83.54%13K
--0
--0
--858K
--442K
Net other financing activities
63.41%-232K
-30.17%-2.14M
40.75%-1M
38.99%-5.85M
-48.35%-1.88M
86.43%-634K
18.17%-1.64M
-2.86%-1.69M
-106.79%-9.59M
---1.27M
Cash from discontinued financing activities
Financing cash flow
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
-100.72%-756K
75.66%-2.6M
-3.14%-1.71M
-40.13%92.21M
-100.62%-847K
Net cash flow
Beginning cash position
26.07%36.42M
136.43%36.06M
139.03%33.49M
-87.84%14.01M
-55.17%27.54M
-55.00%28.89M
-84.04%15.25M
-87.84%14.01M
1,820.21%115.17M
432.65%61.43M
Current changes in cash
908.99%10.98M
-97.30%369K
107.02%2.57M
119.25%19.48M
112.56%5.95M
51.24%-1.36M
143.55%13.64M
106.31%1.24M
-192.66%-101.16M
-145.75%-47.42M
End cash Position
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
139.03%33.49M
-55.17%27.54M
-55.00%28.89M
-84.04%15.25M
-87.84%14.01M
-87.84%14.01M
Free cash flow
113.21%1.22M
-82.20%-17.49M
4.62%-16.49M
39.24%-40.88M
70.27%-4.75M
57.20%-9.24M
18.12%-9.6M
3.85%-17.29M
-88.33%-67.29M
33.93%-15.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M59.26%-8.31M16.56%-8.66M9.00%-15.45M-88.97%-61.76M40.02%-14M
Net income from continuing operations 7.50%-16.11M8.39%-15.48M33.70%-19.89M-54,750.00%-83.07M-70.38%-18.75M-551.42%-17.42M-209.87%-16.9M-255.54%-30M101.39%152K-8.38%-11.01M
Operating gains losses -128.62%-571K-311.38%-2.53M100.35%12K97.63%-622K114.46%1.46M113.00%2M70.22%-615K-367.88%-3.46M-203.19%-26.21M-191.84%-10.09M
Depreciation and amortization -7.36%1.57M14.22%1.52M17.34%1.49M33.14%5.87M32.30%1.58M49.74%1.7M21.04%1.33M28.57%1.27M32.03%4.41M29.57%1.19M
Deferred tax --0--0--071.10%-76K71.75%-126K53.85%80K91.84%-4K-114.44%-26K78.82%-263K-119.43%-446K
Other non cash items 106.67%2.14M-50.22%1.01M102.20%1.56M109.52%5.4M140.63%1.56M138.49%1.04M118.84%2.04M101.95%771K-128.57%-56.77M84.56%-3.84M
Change In working capital 1,131.77%11.46M-289.12%-3.41M42.81%-2.73M111.48%2.36M223.53%6.45M85.38%-1.11M564.58%1.8M40.24%-4.78M-41.77%-20.54M58.85%-5.22M
-Change in receivables 75.90%-493K1,040.91%4.76M-172.46%-16.22M77.13%-4.5M178.12%4.01M66.74%-2.05M86.26%-506K-26.58%-5.95M-558.35%-19.67M-435.82%-5.13M
-Change in inventory 20,366.67%1.22M112.12%232K313.90%2.12M-153.18%-4.39M-272.77%-1.47M99.29%-6K-377.31%-1.91M25.45%-993K5.97%-1.73M269.72%852K
-Change in prepaid assets -93.89%100K-53.27%521K-2,520.83%-629K-26.95%3.13M-45.73%400K-31.59%1.64M60.20%1.12M-105.26%-24K147.10%4.28M108.08%737K
-Change in payables and accrued expense 1,953.56%10.42M-365.56%-8.85M562.80%11.73M319.62%8.16M247.11%3.62M73.97%-562K-0.24%3.33M172.59%1.77M-214.83%-3.72M82.27%-2.46M
-Change in other current assets -107.35%-97K-75.81%410K29.33%1.75M9.05%5.72M-18.65%1.36M-10.45%1.32M44.38%1.7M45.01%1.35M2,750.00%5.25M-81.52%1.67M
-Change in other current liabilities 122.01%320K75.08%-479K-59.76%-1.48M-16.32%-5.77M-65.05%-1.46M36.95%-1.45M-124.53%-1.92M-1.98%-927K-712.86%-4.96M-427.31%-887K
Cash from discontinued investing activities
Operating cash flow 109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M59.26%-8.31M16.56%-8.66M9.00%-15.45M-88.97%-61.76M40.02%-14M
Investing cash flow
Cash flow from continuing investing activities 34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M108.78%7.71M342.67%24.9M1,936.43%18.4M-982.89%-131.61M-255.93%-32.57M
Net PPE purchase and sale 143.23%402K-94.88%-1.83M66.83%-610K17.40%-4.57M56.84%-861K21.85%-930K30.18%-937K-83.53%-1.84M-94.20%-5.53M-129.05%-2M
Net business purchase and sale --0--------48.05%-4.46M66.81%-156K--0--------5.82%-8.58M94.32%-470K
Net investment purchase and sale 15.75%10M-33.64%20M-1.20%20M160.99%71.66M142.00%12.64M109.88%8.64M--30.14M--20.24M---117.51M---30.11M
Cash from discontinued investing activities
Investing cash flow 34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M108.78%7.71M342.67%24.9M1,936.43%18.4M-982.89%-131.61M-255.93%-32.57M
Financing cash flow
Cash flow from continuing financing activities 67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M-100.72%-756K75.66%-2.6M-3.14%-1.71M-40.13%92.21M-100.62%-847K
Net issuance payments of debt -10.00%-11K85.71%-9K50.00%-9K-100.09%-101K47.37%-10K-100.01%-10K-384.62%-63K-38.46%-18K1,616.23%109.94M99.63%-19K
Net common stock issuance --0--------88.68%-1.02M--0---125K-----------9M--0
Proceeds from stock option exercised by employees --0--2K--73K-85.31%126K-74.43%113K-83.54%13K--0--0--858K--442K
Net other financing activities 63.41%-232K-30.17%-2.14M40.75%-1M38.99%-5.85M-48.35%-1.88M86.43%-634K18.17%-1.64M-2.86%-1.69M-106.79%-9.59M---1.27M
Cash from discontinued financing activities
Financing cash flow 67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M-100.72%-756K75.66%-2.6M-3.14%-1.71M-40.13%92.21M-100.62%-847K
Net cash flow
Beginning cash position 26.07%36.42M136.43%36.06M139.03%33.49M-87.84%14.01M-55.17%27.54M-55.00%28.89M-84.04%15.25M-87.84%14.01M1,820.21%115.17M432.65%61.43M
Current changes in cash 908.99%10.98M-97.30%369K107.02%2.57M119.25%19.48M112.56%5.95M51.24%-1.36M143.55%13.64M106.31%1.24M-192.66%-101.16M-145.75%-47.42M
End cash Position 72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M139.03%33.49M-55.17%27.54M-55.00%28.89M-84.04%15.25M-87.84%14.01M-87.84%14.01M
Free cash flow 113.21%1.22M-82.20%-17.49M4.62%-16.49M39.24%-40.88M70.27%-4.75M57.20%-9.24M18.12%-9.6M3.85%-17.29M-88.33%-67.29M33.93%-15.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.25%